[NEJM] Phase 3 Trial of Semaglutide in Metabolic Dysfunction每Associated Steatohepatitis

AmjadAlmansi Post time 2026-10-25 22:27:50 | Show all posts |Read mode
This post will be closed automatically in 2026-10-28 22:26
Reward10points

journalㄩNew England Journal of Medicine

AuthorsㄩArun J. Sanyal; Philip N. Newsome; Iris Kliers; Laura Harms stergaard; Michelle T. Long; Mette Skalshi Kjr; Anna M.G. Cali; Elisabetta Bugianesi; Mary E. Rinella; Michael Roden; Vlad Ratziu

Published dateㄩ2025-6-5

DOIㄩ10.1056/nejmoa2413258

PDF linkㄩhttp://www.nejm.org/doi/pdf/10.1056/NEJMoa2413258

Article linkㄩhttps://doi.org/10.1056/nejmoa2413258

Article SourceㄩMassachusetts Medical Society﹝


Remarkㄩ

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
Georgee Post time 2026-10-25 22:27:51 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Return to the list